According to a new market report published by Lucintel, the future of the bioabsorbable stent/bioresorbable scaffold market looks promising with opportunities in the hospital and cardiac centers markets. The bioabsorbable stent/bioresorbable scaffold market is expected to grow with a CAGR of 12% from 2019 to 2024. The major drivers for this market are high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population.
To download report brochure, please go to https://www.lucintel.com/bioabsorbable-stent-market.aspx and click "report brochure" tab from the menu.
In this market, coronary artery diseases and peripheral artery diseases are the major base of application. Coronary artery diseases are the largest of the bioabsorbable stent/bioresorbable scaffold market.
Polymer and metallic material based stents are used in the bioabsorbable stent/bioresorbable scaffold market. Polymer based stents is the largest segment of the bioabsorbable stent/bioresorbable scaffold market.
Europe will remain the largest region over the forecast period due to more number of CE mark products in the market, increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents.
Abbott, REVA Medical, Elixir Medical, KYOTO MEDICAL PLANNING, BIOTRONIK, Amaranth Medical, Arterial Remodeling Technologies, Meril Life Sciences, Arterius Limited, LEPU MEDICAL TECHNOLOGY, Boston Scientific, 480 Biomedical, S3V Vascular Technologies, Qualimed, and ORBUSNEICH are among the major manufacturers of bioabsorbable stent/bioresorbable scaffold.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the bioabsorbable stent/bioresorbable scaffold market by material, absorption rate, applications, end user, and region. Lucintel has prepared a comprehensive research report titled "Bioabsorbable Stent/Bioresorbable Scaffold Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the bioabsorbable stent/bioresorbable scaffold market by material, absorption rate, applications, end user, and region as follows:
By Material [$M shipment analysis for 2013 – 2024]:
Bioresorbable Polymer Based Stents
Bioresorbable Metallic Stents
By Absorption Rate [$M shipment analysis for 2013 – 2024]:
Slow- absorption Stents
Fast- absorption Stents
By Applications [$M shipment analysis for 2013 – 2024]:
Coronary Artery Diseases
Peripheral Artery Diseases
By End User [$M shipment analysis for 2013 – 2024]:
Hospitals
Cardiac Centers
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Asia-Pacific
ROW
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/bioabsorbable-stent-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.